Literature DB >> 9525592

Characterization of hepatitis G virus (GB-C virus) particles: evidence for a nucleocapsid and expression of sequences upstream of the E1 protein.

J Xiang1, D Klinzman, J McLinden, W N Schmidt, D R LaBrecque, R Gish, J T Stapleton.   

Abstract

Hepatitis G virus (HGV or GB-C virus) is a newly described virus that is closely related to hepatitis C virus (HCV). Based on sequence analysis and by evaluation of translational initiation codon preferences utilized during in vitro translation, HGV appears to have a truncated or absent core protein at the amino terminus of the HGV polyprotein. Consequently, the biophysical properties of HGV may be very different from those of HCV. To characterize HGV particle types, we evaluated plasma from chronically infected individuals with and without concomitant HCV infection by using sucrose gradient centrifugation, isopycnic banding in cesium chloride, and saline density flotation centrifugation. Similar to HCV, HGV particles included an extremely-low-density virion particle (1.07 to 1.09 g/ml) and a nucleocapsid of approximately 1.18 g/ml. One major difference between the particle types was that HGV was consistently more stable in cesium chloride than HCV. Plasma samples from chronically HGV-infected individuals and controls were assessed by a synthetic peptide-based immunoassay to determine if they contained HGV antibody specific for a conserved region in the coding region upstream of the E1 protein. Chronically HGV-infected individuals contained antibody to the HGV core protein peptide, whereas no binding to a hepatitis A virus peptide control was observed. Competitive inhibition of binding to the HGV peptide confirmed the specificity of the assay. These data indicate that HGV has a nucleocapsid and that at least part of the putative core region of HGV is expressed in vivo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9525592      PMCID: PMC109717     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Distribution of hepatitis C virus (HCV) RNA in whole blood and blood cell fractions: plasma HCV RNA analysis underestimates circulating virus load.

Authors:  W N Schmidt; P Wu; J Q Han; M J Perino; D R LaBrecque; J T Stapleton
Journal:  J Infect Dis       Date:  1997-07       Impact factor: 5.226

2.  Surreptitious hepatitis C virus (HCV) infection detected in the majority of patients with cryptogenic chronic hepatitis and negative HCV antibody tests.

Authors:  W N Schmidt; P Wu; J Cederna; F A Mitros; D R LaBrecque; J T Stapleton
Journal:  J Infect Dis       Date:  1997-07       Impact factor: 5.226

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  The role of secretory immunity in hepatitis A virus infection.

Authors:  J T Stapleton; D K Lange; J W LeDuc; L N Binn; R W Jansen; S M Lemon
Journal:  J Infect Dis       Date:  1991-01       Impact factor: 5.226

5.  Hepatitis A virus attachment to cultured cell lines.

Authors:  J T Stapleton; J Frederick; B Meyer
Journal:  J Infect Dis       Date:  1991-12       Impact factor: 5.226

6.  Hepatitis C virus: buoyant density of the factor VIII-derived isolate in sucrose.

Authors:  D Bradley; K McCaustland; K Krawczynski; J Spelbring; C Humphrey; E H Cook
Journal:  J Med Virol       Date:  1991-07       Impact factor: 2.327

7.  Sequence of the structural proteins of tick-borne encephalitis virus (western subtype) and comparative analysis with other flaviviruses.

Authors:  C W Mandl; F X Heinz; C Kunz
Journal:  Virology       Date:  1988-09       Impact factor: 3.616

8.  p26 protein and 33-nm particle associated with nucleocapsid of hepatitis C virus recovered from the circulation of infected hosts.

Authors:  K Takahashi; S Kishimoto; H Yoshizawa; H Okamoto; A Yoshikawa; S Mishiro
Journal:  Virology       Date:  1992-11       Impact factor: 3.616

9.  Neutralizing antibody to hepatitis A virus in immune serum globulin and in the sera of human recipients of immune serum globulin.

Authors:  J T Stapleton; R Jansen; S M Lemon
Journal:  Gastroenterology       Date:  1985-09       Impact factor: 22.682

10.  Extraordinarily low density of hepatitis C virus estimated by sucrose density gradient centrifugation and the polymerase chain reaction.

Authors:  H Miyamoto; H Okamoto; K Sato; T Tanaka; S Mishiro
Journal:  J Gen Virol       Date:  1992-03       Impact factor: 3.891

View more
  24 in total

1.  GB virus C/hepatitis G virus groups and subgroups: classification by a restriction fragment length polymorphism method based on phylogenetic analysis of the 5' untranslated region.

Authors:  J F Quarleri; V L Mathet; M Feld; D Ferrario; M P della Latta; R Verdun; D O Sánchez; J R Oubiña
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

2.  Spontaneous mutations restore the viability of tick-borne encephalitis virus mutants with large deletions in protein C.

Authors:  Regina M Kofler; Agnes Leitner; Gabriel O'Riordain; Franz X Heinz; Christian W Mandl
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor.

Authors:  S Wünschmann; J D Medh; D Klinzmann; W N Schmidt; J T Stapleton
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

Review 4.  Tropism of human pegivirus (formerly known as GB virus C/hepatitis G virus) and host immunomodulation: insights into a highly successful viral infection.

Authors:  Ernest T Chivero; Jack T Stapleton
Journal:  J Gen Virol       Date:  2015-02-09       Impact factor: 3.891

5.  In vitro evolution of high-titer, virus-like vesicles containing a single structural protein.

Authors:  Nina F Rose; Linda Buonocore; John B Schell; Anasuya Chattopadhyay; Kapil Bahl; Xinran Liu; John K Rose
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-10       Impact factor: 11.205

Review 6.  The Strange, Expanding World of Animal Hepaciviruses.

Authors:  Alex S Hartlage; John M Cullen; Amit Kapoor
Journal:  Annu Rev Virol       Date:  2016-09-29       Impact factor: 10.431

7.  In vitro infection of human peripheral blood mononuclear cells by GB virus C/Hepatitis G virus.

Authors:  M Fogeda; S Navas; J Martín; M Casqueiro; E Rodríguez; C Arocena; V Carreño
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

8.  Prospective comparison of whole-blood- and plasma-based hepatitis C virus RNA detection systems: improved detection using whole blood as the source of viral RNA.

Authors:  J T Stapleton; D Klinzman; W N Schmidt; M A Pfaller; P Wu; D R LaBrecque; J q Han; M J Phillips; R Woolson; B Alden
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

9.  GB virus C particles inhibit T cell activation via envelope E2 protein-mediated inhibition of TCR signaling.

Authors:  Nirjal Bhattarai; James H McLinden; Jinhua Xiang; Alan L Landay; Ernest T Chivero; Jack T Stapleton
Journal:  J Immunol       Date:  2013-05-17       Impact factor: 5.422

Review 10.  Human liver transplantation as a model to study hepatitis C virus pathogenesis.

Authors:  Michael G Hughes; Hugo R Rosen
Journal:  Liver Transpl       Date:  2009-11       Impact factor: 5.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.